Switch to:

Beam Therapeutics Accounts Receivable

: $0.00 Mil (As of Mar. 2020)
View and export this data going back to 2020. Start your Free Trial

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Beam Therapeutics's accounts receivables for the quarter that ended in Mar. 2020 was $0.00 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Beam Therapeutics's Days Sales Outstanding for the quarter that ended in Mar. 2020 was 0.00.

In Ben Graham's calculation of liquidation value, accounts receivable are only considered to be worth 75% of book value. Beam Therapeutics's Net-Net Working Capital for the quarter that ended in Mar. 2020 was $192.20 Mil.


Beam Therapeutics Accounts Receivable Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Beam Therapeutics Annual Data
Dec17 Dec18 Dec19
Accounts Receivable 0.00 0.00 0.00

Beam Therapeutics Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Accounts Receivable Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Beam Therapeutics Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Beam Therapeutics Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Beam Therapeutics's Days Sales Outstanding for the quarter that ended in Mar. 2020 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/0.006*91
=0.00

2. In Ben Graham's calculation of liquidation value, Beam Therapeutics's accounts receivable are only considered to be worth 75% of book value:

Beam Therapeutics's liquidation value for the quarter that ended in Mar. 2020 is calculated as:

Liquidation value
=Cash And Cash Equivalents-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=253.442-61.244+0.75 * 0+0.5 * 0
=192.20

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Beam Therapeutics Accounts Receivable Related Terms


Beam Therapeutics Accounts Receivable Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)